Non-Pharmacological Management of Metabolic Syndrome and Selected Endocrinological Diseases

Definition / Overview

Metabolic syndrome is a cluster of cardiometabolic risk factors that substantially elevate the risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). In Australian clinical practice, it is diagnosed when three or more of the following are present:

• Waist circumference: $\geq 94\,\text{cm}$ (men), $\geq 80\,\text{cm}$ (women); thresholds are lower for Asian populations ($\geq 90\,\text{cm}$ men, $\geq 80\,\text{cm}$ women)
• Fasting triglycerides: $\geq 1.7\,\text{mmol/L}$
• HDL cholesterol: $< 1.0\,\text{mmol/L}$ (men), $< 1.3\,\text{mmol/L}$ (women)
• Blood pressure: $\geq 130/85\,\text{mmHg}$ or on antihypertensive therapy
• Fasting plasma glucose: $\geq 5.6\,\text{mmol/L}$ or on glucose-lowering therapy

Non-pharmacological strategies are first-line management for metabolic syndrome and play a central adjunctive role across a range of endocrinological conditions including T2DM, hypothyroidism, hyperthyroidism, polycystic ovarian syndrome (PCOS), Cushing's syndrome, and adrenal insufficiency.

Pathophysiology (Clinically Relevant Mechanisms)

Understanding why lifestyle interventions work informs patient counselling:

• Insulin resistance sits at the core of metabolic syndrome. Excess visceral adipose tissue drives chronic low-grade inflammation, increased free fatty acid flux, and impaired insulin signalling.
• Physical activity improves insulin sensitivity independently of weight loss by upregulating GLUT-4 translocation in skeletal muscle.
• Weight loss reduces hepatic fat, decreases inflammatory cytokines, lowers free androgen levels (relevant in PCOS), and improves sleep-disordered breathing.
• Dietary quality modulates gut microbiome composition, postprandial glycaemia, and hepatic lipid metabolism.
• Sleep and stress dysregulation elevates cortisol and catecholamines, worsening insulin resistance and blood pressure.

Non-Pharmacological Management of Metabolic Syndrome

Dietary Interventions

Diet is the highest-leverage lifestyle intervention for metabolic syndrome. Key approaches supported by evidence:

Practical GP counselling points:

• No single diet is superior for all components; match to patient preference and comorbidities
• Even modest weight loss of $5$-$10\%$ produces clinically meaningful improvements across all five criteria
• Refer to an Accredited Practising Dietitian (APD) via a GP Management Plan (GPMP) and Team Care Arrangement (TCA): MBS items 721/723/732 enable subsidised allied health visits (5 per calendar year)
• Limit ultra-processed foods, sugar-sweetened beverages, and saturated/trans fats
• Reduce sodium intake to $< 2000\,\text{mg/day}$ (approximately 5 g salt) for blood pressure management

Physical Activity

Current Australian guidelines recommend:

• Aerobic exercise: at least 150-300 minutes per week of moderate-intensity aerobic activity (e.g. brisk walking, cycling, swimming), or 75-150 minutes per week of vigorous-intensity activity
• Resistance training: at least 2 sessions per week targeting major muscle groups; independently improves insulin sensitivity and basal metabolic rate
• Reduce sedentary time: even breaking up prolonged sitting with brief activity bouts (2-3 minutes every 30 minutes) has measurable metabolic benefit
• Step target: 7000-10,000 steps per day is a practical proxy for moderate activity

Refer to an Exercise Physiologist (AEP) via TCA for patients with comorbidities (e.g. osteoarthritis limiting exercise options, cardiac disease requiring supervised exercise).

Weight Management

• Behavioural weight loss programs: structured programs combining dietary, physical activity, and psychological support achieve greater weight loss than brief advice alone
• Very low energy diets (VLED): $< 800\,\text{kcal/day}$ under medical supervision; effective for rapid weight loss and T2DM remission (evidence from DiRECT trial principles)
• Motivational interviewing (MI): a GP-applicable communication technique that elicits intrinsic motivation for change; more effective than directive advice
• Self-monitoring: encourage food diaries, smartphone apps, and regular weight measurement (weekly or fortnightly)
• Bariatric surgery referral: consider when BMI $\geq 40\,\text{kg/m}^2$, or BMI $\geq 35\,\text{kg/m}^2$ with significant comorbidities, after failure of sustained lifestyle and pharmacological attempts

Sleep and Stress Management

• Obstructive sleep apnoea (OSA): screen all patients with metabolic syndrome using the STOP-BANG questionnaire; OSA worsens insulin resistance and hypertension independently; CPAP therapy is a non-pharmacological intervention improving metabolic parameters
• Stress reduction: chronic psychological stress elevates cortisol, worsens glycaemia, and promotes abdominal fat deposition; mindfulness-based stress reduction (MBSR) and cognitive behavioural therapy (CBT) have evidence in metabolic syndrome
• Sleep hygiene: target 7-9 hours of quality sleep per night; poor sleep duration and quality impairs glucose metabolism

Smoking Cessation

• Smoking independently worsens insulin resistance and CVD risk; cessation is part of metabolic syndrome management even though short-term weight gain post-cessation is common
• Provide brief intervention using the 5As framework (Ask, Advise, Assess, Assist, Arrange); refer to Quitline (13 7848)

Alcohol Reduction

• Target $\leq 10$ standard drinks per week (Australian guidelines); heavy alcohol intake raises triglycerides and blood pressure significantly
• Even modest reductions produce measurable triglyceride and blood pressure benefits

Non-Pharmacological Management of Selected Endocrinological Conditions

Type 2 Diabetes Mellitus

Non-pharmacological strategies are foundational; HbA1c improvements of $1$-$2\%$ are achievable through lifestyle alone in early disease.

Dietary approaches:

• Carbohydrate quality and quantity are both important; consistent carbohydrate distribution across meals aids glycaemic control
• Low-carbohydrate and very-low-carbohydrate diets produce greater short-term glycaemic improvement but require monitoring for hypoglycaemia if on sulfonylureas or insulin
• Encourage low-GI carbohydrates, high-fibre foods, and minimise added sugars

Physical activity:

• Postprandial walking (10-15 minutes after meals) is particularly effective at blunting postprandial glucose spikes
• Both aerobic and resistance exercise are recommended; combination is superior to either alone

Structured diabetes education:

• Refer to a Credentialled Diabetes Educator (CDE) via TCA
• National Diabetes Services Scheme (NDSS) registration provides subsidised consumables and education resources
• Self-monitoring of blood glucose (SMBG): frequency depends on treatment; lifestyle-managed patients may benefit from structured intermittent monitoring (e.g. paired testing before and 2 hours after meals)

Foot care:

• Regular podiatry referral for risk assessment and patient education on foot inspection
• High-risk feet: refer to a multidisciplinary footcare team

Polycystic Ovarian Syndrome (PCOS)

Non-pharmacological management is particularly important given the reproductive and metabolic dimensions:

• Weight loss: even $5\%$ body weight loss restores ovulation in a significant proportion of women with PCOS and obesity; reduces androgen levels, improves menstrual regularity, and lowers insulin resistance
• Dietary approach: no specific diet is superior; energy restriction with adequate protein and fibre is the practical recommendation; the Mediterranean diet is a reasonable choice
• Exercise: both aerobic and resistance training improve insulin sensitivity and reduce androgen levels independent of weight loss
• Psychological support: PCOS carries high rates of depression, anxiety, and body image concerns; screen using validated tools (PHQ-9, GAD-7) and refer for psychological support (CBT via Mental Health Treatment Plan, MBS items 2700-2717)
• Lifestyle in fertility: for women seeking fertility, lifestyle optimisation should precede or accompany ovulation induction to improve outcomes and reduce obstetric risks

Hypothyroidism

The primary management is thyroid hormone replacement (levothyroxine); however, non-pharmacological measures support overall wellbeing:

• Dietary iodine adequacy: ensure adequate iodine intake (Australian women of reproductive age and pregnant women: supplemental iodine 150 mcg/day via pregnancy multivitamin); endemic goitre from severe iodine deficiency is managed by iodine supplementation
• Selenium: adequate selenium intake supports thyroid hormone metabolism; frank deficiency should be corrected (dietary sources: Brazil nuts, seafood)
• Exercise: fatigue and weight gain are common symptoms; graded physical activity assists with energy levels and weight management; counsel that exercise capacity improves as euthyroidism is achieved
• Timing of medication: advise patients to take levothyroxine on an empty stomach 30-60 minutes before food; avoid concurrent calcium, iron, or soy as these impair absorption (this is technically adherence advice but non-pharmacological in nature)
• Monitoring: TSH monitoring 6-8 weeks after dose change; once stable, annual TSH

Hyperthyroidism / Graves' Disease

Beyond antithyroid drugs, radioiodine, or surgery:

• Rest and stress reduction: high sympathetic drive worsens symptoms; adequate rest and stress management reduce adrenergic symptoms
• Nutrition: hyperthyroidism is a hypermetabolic state; ensure adequate caloric intake to prevent weight loss; calcium and vitamin D supplementation to mitigate bone loss (thyrotoxicosis accelerates bone turnover)
• Eye care in Graves' ophthalmopathy: smoking cessation is the single most important modifiable risk factor for progression of thyroid eye disease; use lubricating eye drops for ocular surface disease; sleep with head elevated if periorbital oedema present; UV-protective sunglasses
• Avoid excess iodine: high-iodine foods (e.g. kelp supplements, amiodarone) can exacerbate hyperthyroidism; counsel appropriately

Cushing's Syndrome

Management is primarily surgical (resection of causative tumour) or involves modifying exogenous corticosteroid use, but lifestyle measures are relevant:

• Steroid-induced Cushing's: when iatrogenic, review the indication for corticosteroids with the prescribing specialist and explore the minimum effective dose or steroid-sparing agents; this discussion is a non-pharmacological systems-level intervention
• Weight-bearing exercise: mitigates osteoporosis and proximal myopathy associated with hypercortisolism
• Calcium and vitamin D: adequate dietary intake ($1000$-$1300\,\text{mg/day}$ calcium; vitamin D replete) is critical alongside pharmacological bone protection
• Mental health support: Cushing's syndrome causes significant psychiatric morbidity (depression, anxiety, cognitive impairment); psychological referral is appropriate

Adrenal Insufficiency (Primary / Secondary)

Non-pharmacological aspects centre on sick-day management and patient education:

• Sick-day rules: patients must be educated on doubling or tripling their hydrocortisone dose during intercurrent illness, surgery, or physiological stress; failure to do so risks adrenal crisis (a life-threatening emergency)
• Medic alert identification: all patients with adrenal insufficiency should wear a medical alert bracelet and carry an emergency hydrocortisone injection kit (with training on self- or carer-administration)
• Dietary salt: patients with primary adrenal insufficiency (Addison's disease) have aldosterone deficiency; liberal salt intake and avoiding dehydration in hot weather or during exercise is important
• Stress management: while cortisol replacement is fixed, patients should understand that psychosocial stressors may require temporary dose adjustment (under specialist guidance)

Complications and Special Considerations

Aboriginal and Torres Strait Islander Peoples

• Metabolic syndrome and T2DM prevalence is significantly higher; earlier onset and more aggressive progression are well-documented
• Close the Gap PBS co-payment measure provides free or reduced-cost medicines; registrars should be familiar with eligibility
• Culturally safe communication: involve family and community where appropriate; consider Aboriginal Health Workers and Torres Strait Islander Health Practitioners in the care team
• Lifestyle interventions must be culturally adapted: consider traditional foods, community food environments, and social determinants of health

Paediatric and Adolescent Considerations

• Childhood obesity and early metabolic syndrome: family-based behavioural interventions are more effective than individual child-focused programs
• Screen adolescents with obesity for PCOS, impaired glucose regulation, and dyslipidaemia
• Physical activity targets: 60 minutes of moderate-to-vigorous activity daily for children and adolescents

Older Adults (75+ Health Assessment)

• MBS item 715 (75+ health check): opportunity to assess metabolic risk factors, review polypharmacy contributing to weight gain or glucose dysregulation, and address functional barriers to physical activity
• Exercise prescription should consider falls risk, musculoskeletal limitations, and cardiac status
• Balance benefit vs risk: aggressive dietary restriction in the elderly may worsen sarcopenia and frailty

GP Management Framework and Structured Care

Key GP actions at each review:

1. Measure waist circumference, weight, and BP at every chronic disease review
2. Reinforce lifestyle goals; acknowledge and celebrate incremental progress
3. Screen for depression and anxiety (PHQ-9, K10) given high comorbidity with metabolic and endocrine disorders
4. Coordinate the multidisciplinary team via TCA; avoid doing everything yourself
5. Ensure culturally safe and health-literate communication; use teach-back technique

Sources

• MBS Online (Medicare Benefits Schedule)
• PBS Schedule (Pharmaceutical Benefits Scheme)